Abstract
150 © 2011, INASL Result: Early diagnosis of HCC remains a key goal in improving prognosis. In general, systemic chemotherapy has not been shown any survival benefit and cannot be recommended outside clinical trials. Early referral for partial hepatectomy and live transplantation may offer the best chance of cure in patients with resectable tumor. Development of adjuvant therapy with nonsurgical ablation and downstaging strategy also increases the chance of cure.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
